Information Provided By: 
Fly News Breaks for February 23, 2018
AGN
Feb 23, 2018 | 07:36 EDT
SunTrust analyst John Boris initiated Allergan with a Buy and a price target of $200, anticipating a "more consistent pattern of execution" due to manageable Botox competition and a promising pipeline. Boris adds that given the 50% decline in the stock price over the past 2 years on patent expiration and uneven performance, Allergan stock appears attractive at current levels given that the issues weighing on shares have likely played out.
News For AGN From the Last 2 Days
There are no results for your query AGN
